SLC16A1 and head and neck squamous cell carcinoma: To address this gap, our study integrated bioinformatics analysis with clinical patient samples to reveal that SLC16A1 is highly expressed in HNSCC and that higher expression levels are strongly correlated with poorer patient outcomes.